Weill Cornell Medicine receives NIH grant to lead a national contraceptive research center

Weill Cornell Medicine has received a three-year, nearly $6 million grant to lead one of three national contraceptive research centers.

Pharmalittle: European patent agency invalidates a Moderna mRNA patent; pharma ally Eshoo plans to retire

Good morning! This is Jonathan Wosen, West Coast biotech and life sciences reporter, filling in for Ed Silverman while he’s away from the Pharmalot campus.

November 22, 2023

Lilly’s pipeline drug retatrutide sets new threshold for weight loss at medical meeting reveal

Eli Lilly’s experimental weight loss drug GLP-1 appears to have set a new bar, helping obese patients in a Phase II study lose 24% of

June 27, 2023

Bispecific Antibody Shows Clinical Activity in Recurrent Ovarian Cancer

SEOUL, South Korea — Treatment with the bispecific antibody ubamatamab alone or in combination with the PD-1 inhibitor cemiplimab (Libtayo) appeared to be safe and

November 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.